Filing Details
- Accession Number:
- 0001144204-11-045468
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-08-11 07:36:15
- Reporting Period:
- 2011-08-10
- Filing Date:
- 2011-08-11
- Accepted Time:
- 2011-08-11 07:36:15
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1114220 | Keryx Biopharmaceuticals Inc | KERX | Pharmaceutical Preparations (2834) | 134087132 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1413525 | P. Michael Tarnok | C/O Keryx Biopharmaceuticals, Inc. 750 Lexington Avenue New York NY 10022 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2011-08-10 | 15,000 | $3.10 | 261,100 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- Of the 261,100 shares, 25,000 shares are restricted common stock.